ABSTRACT
Implantation of a cardiac pacemaker was seriously considered, but it was decided to evaluate the effect of treatment with antiepileptic drugs first. Valproate was chosen because of the risk of cardiodepressive effects of carbamazepine. The patient was put on valproate 1200 mg/day, which has rendered her completely seizure-free.
